245 related articles for article (PubMed ID: 38481662)
21. [Molecular detection and genotyping of human papillomavirus].
Tian YB; Zhang CT
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):729-735. PubMed ID: 30392336
[TBL] [Abstract][Full Text] [Related]
22. [Application of isothermal HPV DNA amplification test in cervical cancer screening].
Wang L; Jiang MY; Qin Y; Li L; Wu ZN; Li TY; Wu T; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):313-318. PubMed ID: 29730922
[No Abstract] [Full Text] [Related]
23. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
Syrjänen K
Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
[TBL] [Abstract][Full Text] [Related]
24. Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea.
Jung S; Lee B; Lee KN; Kim Y; Oh EJ
Arch Pathol Lab Med; 2016 Mar; 140(3):276-80. PubMed ID: 26927723
[TBL] [Abstract][Full Text] [Related]
25. Rapid In Situ Hydrogel LAMP for On-Site Large-Scale Parallel Single-Cell HPV Detection.
Wang J; Jing G; Huang W; Xin L; Du J; Cai X; Xu Y; Lu X; Chen W
Anal Chem; 2022 Dec; 94(51):18083-18091. PubMed ID: 36517452
[TBL] [Abstract][Full Text] [Related]
26. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of combined detection of thinprep cytology test and high risk human papillomavirus hybrid capture 2 assay in the screening and recurrence predication of cervical intraepithelial neoplasia].
Xu XY; Zhao W; Li GJ; Jin XY; Li YZ
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2503-5. PubMed ID: 23158720
[TBL] [Abstract][Full Text] [Related]
28. Detection and typing of human papillomavirus nucleic acids in biological fluids.
Coutlée F; Mayrand MH; Roger M; Franco EL
Public Health Genomics; 2009; 12(5-6):308-18. PubMed ID: 19684443
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus testing methods.
Hubbard RA
Arch Pathol Lab Med; 2003 Aug; 127(8):940-5. PubMed ID: 12873165
[TBL] [Abstract][Full Text] [Related]
31. Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low- and middle-income countries.
Tanzi E; Bianchi S; Fappani C; Gori M; Colzani D; Passera I; Tincati C; Canuti M; Raviglione M; Amendola A
J Med Virol; 2023 May; 95(5):e28802. PubMed ID: 37219045
[TBL] [Abstract][Full Text] [Related]
32. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
33. Triple signal amplification strategy for the ultrasensitive electrochemical detection of human papillomavirus 16 E6/E7 mRNA.
Yang N; Liu P; Cai C; Zhang R; Sang K; Shen P; Huang Y; Lu Y
Enzyme Microb Technol; 2021 Sep; 149():109855. PubMed ID: 34311892
[TBL] [Abstract][Full Text] [Related]
34. A simple and rapid diagnostic method for 13 types of high-risk human papillomavirus (HR-HPV) detection using CRISPR-Cas12a technology.
Gong J; Zhang G; Wang W; Liang L; Li Q; Liu M; Xue L; Tang G
Sci Rep; 2021 Jun; 11(1):12800. PubMed ID: 34140632
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a Chip-Based, Point-of-Care, Portable, Real-Time Micro PCR Analyzer for the Detection of High-Risk Human Papillomavirus in Uterine Cervix in India.
Hariprasad R; Tulsyan S; Babu R; Dhanasekaran K; Thakur N; Hussain S; Tripathi R; Sreenivas V; Sharma S; Sriram L; Singh S; Mehrotra R
JCO Glob Oncol; 2020 Jul; 6():1147-1154. PubMed ID: 32697666
[TBL] [Abstract][Full Text] [Related]
36. [HPV primary test in the cervical cancer screening: reproducibility assessment and investigation on cytological outcome of Hybrid Capture 2 borderline samples].
Burroni E; Sani C; Bisanzi S; Ocello C
Epidemiol Prev; 2016; 40(3-4):164-70. PubMed ID: 27436249
[TBL] [Abstract][Full Text] [Related]
37. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.
Riethmuller D; Gay C; Bertrand X; Bettinger D; Schaal JP; Carbillet JP; Lassabe C; Arveux P; Seilles E; Mougin C
Diagn Mol Pathol; 1999 Sep; 8(3):157-64. PubMed ID: 10565688
[TBL] [Abstract][Full Text] [Related]
38. Development and application of a rapid detection system for human papillomavirus and Herpes simplex virus-2 by loop-mediated isothermal amplification assay.
Yang JF; Zhao CZ; Lu KX
Microb Pathog; 2016 Aug; 97():178-82. PubMed ID: 27287497
[TBL] [Abstract][Full Text] [Related]
39. A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care.
Chang MM; Ma A; Novak EN; Barra M; Kundrod KA; Montealegre JR; Scheurer ME; Castle PE; Schmeler K; Richards-Kortum R
Sci Rep; 2023 Nov; 13(1):20397. PubMed ID: 37989845
[TBL] [Abstract][Full Text] [Related]
40. An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
Kundrod KA; Barra M; Wilkinson A; Smith CA; Natoli ME; Chang MM; Coole JB; Santhanaraj A; Lorenzoni C; Mavume C; Atif H; Montealegre JR; Scheurer ME; Castle PE; Schmeler KM; Richards-Kortum RR
Sci Transl Med; 2023 Jun; 15(701):eabn4768. PubMed ID: 37343083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
